Exploring the Role of NCX1 and NCX3 in an In Vitro Model of Metabolism Impairment: Potential Neuroprotective Targets for Alzheimer’s Disease. Here, SLC8A3 is linked to early-onset autosomal dominant Alzheimer disease.